Cybersight AI is the latest Orbis tool being used by health teams around the world to diagnose and treat diabetic retinopathy (DR). DR is a potentially blinding disease that can affect anyone with diabetes. It is especially common in Sub-Saharan Africa, the region with the fastest growing prevalence of diabetes.
In partnership with the Rwanda Diabetes Association, we’ve equipped four clinics across Rwanda with AI screening cameras. With these cameras, powered by Cybersight AI, clinicians can now diagnose patients in minutes, improving patient outcomes and satisfaction.
Orbis studies show that when patients get real-time diagnosis of diabetic retinopathy through AI screening in a primary care setting such as a rural diabetes clinic—rather than waiting weeks or months for a specialist to review—they are more likely to seek treatment and have higher satisfaction scores.